The cathepsin family and their role in colorectal cancer
- PMID: 18573619
- DOI: 10.1016/j.prp.2008.04.010
The cathepsin family and their role in colorectal cancer
Abstract
Cathepsins are a class of globular proteases, initially described as intracellular peptide hydrolases, although several cathepsins also have extracellular functions. Cathepsins B, C, F, H, L, K, O, S, V, W, and X are cysteine proteases of the papain family, and represent the largest and best-known class of the cathepsins. Cathepsin G is a serine carboxypeptidases, and cathepsins D and E are aspartic proteases. Cathepsins are synthesized as inactive proenzymes and processed to become mature and active enzymes. Endogenous protein inhibitors, such as cystatins and some serpins, inhibit active enzymes. As primarily lysosomal proteases, cathepsins play important roles in proteolysis during physiological processes, as well as in several diseases. On the basis of their ability to degrade extracellular matrix proteins, cathepsins have been implicated to play a role in invasion and metastasis of colorectal cancer. In the present review, the role of cathepsins in the disease process of colorectal cancers and the correlation of cathepsin expression and activity with clinicopathological features is discussed. Furthermore, we give an overview of the recent developments of cathepsins in animal models and in in vitro experiments of colorectal disease, and provide information on inhibitors of cathepsins as possible therapeutics.
Similar articles
-
Cysteine proteinases in cancer progression and their clinical relevance for prognosis.Biol Chem. 1998 Feb;379(2):125-30. Biol Chem. 1998. PMID: 9524063 Review.
-
Inhibitors of proteases as anticancer drugs.Neoplasma. 2005;52(3):185-92. Neoplasma. 2005. PMID: 15875078 Review.
-
Cysteine cathepsins in human cancer.Biol Chem. 2004 Nov;385(11):1017-27. doi: 10.1515/BC.2004.132. Biol Chem. 2004. PMID: 15576321 Review.
-
Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.Lung Cancer. 2009 Apr;64(1):79-85. doi: 10.1016/j.lungcan.2008.07.005. Epub 2008 Aug 29. Lung Cancer. 2009. PMID: 18760860
-
Cysteine cathepsin proteases as pharmacological targets in cancer.Trends Pharmacol Sci. 2008 Jan;29(1):22-8. doi: 10.1016/j.tips.2007.10.011. Epub 2007 Nov 26. Trends Pharmacol Sci. 2008. PMID: 18037508 Review.
Cited by
-
Inferring serum proteolytic activity from LC-MS/MS data.BMC Bioinformatics. 2012 Apr 12;13 Suppl 5(Suppl 5):S7. doi: 10.1186/1471-2105-13-S5-S7. BMC Bioinformatics. 2012. PMID: 22537011 Free PMC article.
-
Role of Glycosaminoglycans in Procathepsin B Maturation: Molecular Mechanism Elucidated by a Computational Study.J Chem Inf Model. 2020 Apr 27;60(4):2247-2256. doi: 10.1021/acs.jcim.0c00023. Epub 2020 Apr 1. J Chem Inf Model. 2020. PMID: 32155059 Free PMC article.
-
Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins.Chem Biol. 2015 Jan 22;22(1):148-58. doi: 10.1016/j.chembiol.2014.11.008. Epub 2015 Jan 8. Chem Biol. 2015. PMID: 25579207 Free PMC article.
-
Expression and Localization of Cathepsins B, D and G in Cancer Stem Cells in Liver Metastasis From Colon Adenocarcinoma.Front Surg. 2018 Jun 7;5:40. doi: 10.3389/fsurg.2018.00040. eCollection 2018. Front Surg. 2018. PMID: 30177970 Free PMC article.
-
Cathepsin B: multiple roles in cancer.Proteomics Clin Appl. 2014 Jun;8(5-6):427-37. doi: 10.1002/prca.201300105. Epub 2014 Mar 26. Proteomics Clin Appl. 2014. PMID: 24677670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials